HK1076743A1 - Orodispersible pharmaceutical composition comprising perindopril - Google Patents

Orodispersible pharmaceutical composition comprising perindopril

Info

Publication number
HK1076743A1
HK1076743A1 HK05108936.5A HK05108936A HK1076743A1 HK 1076743 A1 HK1076743 A1 HK 1076743A1 HK 05108936 A HK05108936 A HK 05108936A HK 1076743 A1 HK1076743 A1 HK 1076743A1
Authority
HK
Hong Kong
Prior art keywords
perindopril
pharmaceutical composition
orodispersible pharmaceutical
orodispersible
composition
Prior art date
Application number
HK05108936.5A
Other languages
English (en)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1076743A1 publication Critical patent/HK1076743A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK05108936.5A 2002-01-23 2005-10-10 Orodispersible pharmaceutical composition comprising perindopril HK1076743A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200790A FR2834893B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de perindopril
PCT/FR2003/000200 WO2003061691A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible de perindopril

Publications (1)

Publication Number Publication Date
HK1076743A1 true HK1076743A1 (en) 2006-01-27

Family

ID=27589554

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108936.5A HK1076743A1 (en) 2002-01-23 2005-10-10 Orodispersible pharmaceutical composition comprising perindopril

Country Status (27)

Country Link
US (3) US20050106237A1 (es)
EP (1) EP1467750B1 (es)
JP (1) JP4090997B2 (es)
KR (1) KR100588224B1 (es)
CN (1) CN1658898B (es)
AR (1) AR038305A1 (es)
AT (1) ATE332690T1 (es)
AU (1) AU2003215708B2 (es)
BR (1) BRPI0307048B1 (es)
CA (1) CA2473205C (es)
CY (1) CY1105655T1 (es)
DE (1) DE60306747T2 (es)
DK (1) DK1467750T3 (es)
EA (1) EA007181B1 (es)
ES (1) ES2268372T3 (es)
FR (1) FR2834893B1 (es)
GE (1) GEP20063821B (es)
HK (1) HK1076743A1 (es)
MA (1) MA27099A1 (es)
MX (1) MXPA04007195A (es)
NO (1) NO333723B1 (es)
NZ (1) NZ533821A (es)
PL (1) PL205473B1 (es)
PT (1) PT1467750E (es)
UA (1) UA78279C2 (es)
WO (1) WO2003061691A1 (es)
ZA (1) ZA200405009B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080234353A1 (en) * 2004-03-24 2008-09-25 Reynir Eyjolfsson Formulations of Ramipril
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
SK50252005A3 (sk) * 2005-03-22 2006-10-05 Vúlm, A.S. Farmaceutický prípravok obsahujúci perindopril erbumín, spôsob jeho prípravy a stabilizácie
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
HRP20190677T4 (hr) 2013-12-23 2023-02-03 Dr. Falk Pharma Gmbh Optimizirana farmaceutska formula za liječenje upalnih promjena u jednjaku
US20170042806A1 (en) * 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
DE69532110T2 (de) * 1994-01-31 2004-09-09 Yamanouchi Pharmaceutical Co., Ltd. Intraoral löslicher formpressling und verfahren zu seiner herstellung
DE69901938T3 (de) * 1998-03-06 2012-08-02 Aptalis Pharma S.R.L. Schnell zerfallende tablette
US6740339B1 (en) * 1999-06-18 2004-05-25 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
ATE371439T1 (de) * 2000-07-27 2007-09-15 Roquette Freres Granulat bestehend aus stärke und laktose
US6651768B2 (en) * 2000-11-06 2003-11-25 Bombardier Inc. Snowmobile engine mount
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
KR20040078130A (ko) 2004-09-08
EP1467750A1 (fr) 2004-10-20
JP4090997B2 (ja) 2008-05-28
NZ533821A (en) 2005-08-26
GEP20063821B (en) 2006-05-10
AU2003215708B8 (en) 2003-09-02
CA2473205C (fr) 2010-05-18
PT1467750E (pt) 2006-11-30
PL370162A1 (en) 2005-05-16
UA78279C2 (en) 2007-03-15
MXPA04007195A (es) 2004-10-29
FR2834893A1 (fr) 2003-07-25
CA2473205A1 (fr) 2003-07-31
DE60306747D1 (de) 2006-08-24
DE60306747T2 (de) 2007-08-02
CN1658898A (zh) 2005-08-24
BRPI0307048B1 (pt) 2015-06-30
EA007181B1 (ru) 2006-08-25
CN1658898B (zh) 2012-10-03
NO333723B1 (no) 2013-09-02
ES2268372T3 (es) 2007-03-16
US20120076856A1 (en) 2012-03-29
EA200400884A1 (ru) 2004-12-30
AU2003215708B9 (en) 2003-09-02
JP2005523256A (ja) 2005-08-04
PL205473B1 (pl) 2010-04-30
ZA200405009B (en) 2005-08-31
MA27099A1 (fr) 2004-12-20
EP1467750B1 (fr) 2006-07-12
AR038305A1 (es) 2005-01-12
ATE332690T1 (de) 2006-08-15
CY1105655T1 (el) 2010-12-22
WO2003061691A1 (fr) 2003-07-31
KR100588224B1 (ko) 2006-06-12
DK1467750T3 (da) 2006-11-13
FR2834893B1 (fr) 2004-02-27
BR0307048A (pt) 2004-10-26
US20100267799A1 (en) 2010-10-21
US20050106237A1 (en) 2005-05-19
NO20043473L (no) 2004-08-20
AU2003215708B2 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
HK1076743A1 (en) Orodispersible pharmaceutical composition comprising perindopril
HK1076742A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
AU2003291103A8 (en) Pharmaceutical composition
GB0213739D0 (en) Pharmaceutical compositions
HK1161123A1 (zh) 含有奧曲肽微顆粒的藥物組合物
AU2003220786A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
HK1076741A1 (en) Orodispersible pharmaceutical composition comprising ivabradine
IL164547A0 (en) Pharmaceutical composition
AP2004003154A0 (en) Novel perindopril salt and pharmaceutical compositions containing same.
IL165878A0 (en) Pharmaceutical composition
AU2003215708A1 (en) Orodispersible pharmaceutical composition comprising perindopril
IL173626A0 (en) Small peptides and oral pharmaceutical compositions containing the same
AU2003215706A1 (en) Orodispersible pharmaceutical composition comprising ivabradine
GB0213481D0 (en) Pharmaceutical compositions
HK1065477A1 (en) Pharmaceutical composition
SI1467750T1 (sl) Farmacevtski sestavek perindoprila disperzen v ustih (orodisperzen)
GB0217703D0 (en) Pharmaceutical composition
AU2003219239A1 (en) Orodispersible pharmaceutical composition comprising mitiglinide
AU2003219238A1 (en) Orodispersible pharmaceutical composition comprising testosterone
GB0211355D0 (en) Pharmaceutical composition
GB0210905D0 (en) Pharmaceutical composition
GB0214491D0 (en) Pharmaceutical composition
GB0213306D0 (en) Pharmaceutical composition
GB0213305D0 (en) Pharmaceutical composition
GB0213267D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190122